Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (273)	1/9/1999 4:46:00 PM
From: ArtAlley	Read Replies (1) \| Respond to of 3044

RICHARD: any info on the buyout of ASCT by Parke Davis...? ASCT has two new drugs looking for approval by the FDA...so, possibly this isn't a good deal for them? From what I have heard the buyout should take them from about $4.00 to somewhere around $12.00. If the buyout does not occur they could go to $20.00 with FDA approval...thanks, Art

To: scaram(o)uche who wrote (273)	1/10/1999 12:07:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 3044

It's probably all the internuts thinking it's a year 2000 stock <G>. Actually, it's interesting that "millennium" is one of the most commonly misspelled words (like in the title of this thread!). Do a Usenet search for "millenium" and "milennium" on DejaNews or AltaVista and you'll see what I mean. My own suggestion is that at midnight on 12/31/99 the masses can celebrate the turn of the "millenium/milennium" and the pedants can wait until 12/31/2000 to celebrate the turn of the "millennium." BTW, for an interesting article on pharmacogenomics, check out: medscape.com The recent acquisition by Quintiles is also worth noting. Peter (celebrating Millennium's performance this week)